Evidence map›Paper›PMID 37079537›Full record

ArticlePLoS biology2023

A comparison of anatomic and cellular transcriptome structures across 40 human brain diseases.

Yashar Zeighami, Trygve E Bakken, Thomas Nickl-Jockschat, Zeru Peterson, Anil G Jegga, Jeremy A Miller, Jay Schulkin, Alan C Evans, Ed S Lein, Michael Hawrylycz

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Yashar ZeighamiDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, Canada.ORCID 0000-0002-0583-5811
Trygve E BakkenAllen Institute for Brain Science, Seattle, Washington, United States of America.
Thomas Nickl-JockschatDepartment of Psychiatry, Neuroscience and Pharmacology, Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, United States of America.
Zeru PetersonDepartment of Psychiatry, Neuroscience and Pharmacology, Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, United States of America.
Anil G JeggaDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Jeremy A MillerAllen Institute for Brain Science, Seattle, Washington, United States of America.
Jay SchulkinDepartment of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America.
Alan C EvansMontreal Neurological Institute, McGill University, Montreal, Canada.
Ed S LeinAllen Institute for Brain Science, Seattle, Washington, United States of America.
Michael HawrylyczAllen Institute for Brain Science, Seattle, Washington, United States of America.
Allen Institute for Brain Science · USMontreal Neurological Institute and Hospital · CAUniversity of Iowa · USCincinnati Children's Hospital Medical Center · USUniversity of Washington · US

Funding

University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)P50HD103556 · NICHD · UNIVERSITY OF IOWA · PI EDWIN TED G. ABEL, Lane Strathearn · 2021 to 2026
$8.5M
A Community Framework for Data-driven Brain Transcriptomic Cell Type Definition, Ontology, and NomenclatureRF1MH123220 · NIMH · ALLEN INSTITUTE · PI HAWRYLYCZ, MICHAEL, LEIN, ED · 2020 to 2020
$2.8M
Neurophysiological markers of HAND and the impact of aging: Evidence from MEGR01MH103220 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WILSON, TONY W · 2014 to 2018
$2.5M
NICHD NIH HHS P50 HD103556NIMH NIH HHS R01 MH103220NIMH NIH HHS RF1 MH123220
6 · The paper itself

Abstract

Genes associated with risk for brain disease exhibit characteristic expression patterns that reflect both anatomical and cell type relationships. Brain-wide transcriptomic patterns of disease risk genes provide a molecular-based signature, based on differential co-expression, that is often unique to that disease. Brain diseases can be compared and aggregated based on the similarity of their signatures which often associates diseases from diverse phenotypic classes. Analysis of 40 common human brain diseases identifies 5 major transcriptional patterns, representing tumor-related, neurodegenerative, psychiatric and substance abuse, and 2 mixed groups of diseases affecting basal ganglia and hypothalamus. Further, for diseases with enriched expression in cortex, single-nucleus data in the middle temporal gyrus (MTG) exhibits a cell type expression gradient separating neurodegenerative, psychiatric, and substance abuse diseases, with unique excitatory cell type expression differentiating psychiatric diseases. Through mapping of homologous cell types between mouse and human, most disease risk genes are found to act in common cell types, while having species-specific expression in those types and preserving similar phenotypic classification within species. These results describe structural and cellular transcriptomic relationships of disease risk genes in the adult brain and provide a molecular-based strategy for classifying and comparing diseases, potentially identifying novel disease relationships.

Indexed as

Brain DiseasesTranscriptomeAdultAnimalsBasal GangliaBrainGene Expression ProfilingHumansMiceRisk Factors

Identifiers

PMID37079537
PMCPMC10118126
OpenAlexW4366464124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.